Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06503341

A Hospital-Based Registry of Preventive Cardiology Clinics

More research is needed to articulate the most effective ways to use these tools as screening tests in cardiovascular risk assessments and how they ultimately affect CVD mortality and morbidity outcomes. Clinicians are encouraged to continue sharing decision-making with patients to combine their unique cardiovascular risk factors and develop a comprehensive, effective treatment plan.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cardiovascular Morbidity Cardiovascular Risk Assesment Primary Prevention CVD

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Institute of Cardiovascular Diseases

Karachi, Sindh, 75510, Pakistan

Location status: Recruiting

Location contact

Dr Rubina Rauf

CONTACT

[email protected]

+923002947117

About this study

Study Design: observational study Duration of Study: ongoing. Sample Size: All patients presenting to preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan..

Sampling Technique: Non-probability consecutive sampling Data Collection Procedure: Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality. Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, will be included in this registry. Demographic characteristics, physical examination, clinical history, risk modification, lab assessment, and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire.

Data Analysis Procedure: The Tentative analysis plan uses collected data for research publications. The statistical package for social sciences (SPSS 21) will be used to analyze baseline characteristics. The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative (continuous) variables. Descriptive statistics such as mean ± SD, median (IQR), skewness, maximum, and minimum will be calculated for quantitative (continuous) variables. Frequency and percentages will be calculated for categorical variables.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All individuals attending the preventive cardiology clinics.

Exclusion criteria

  • • Individuals who refused to give consent.

Treatment and study plan

Cardiovascular risk assesment

Other

ASCVD Score and WHO Cardiovascular Risk score.

Primary outcomes

  1. cardiovascular risk assesesment

    Time frame: Ten years

    risk stratification of Cardiovascular diseases (CVD) in patients without established CVD but with CVD co morbids.we are using Atherosclerotic Cardiovascular Diseases (ASCVD) Risk Score and World Heart Organization(WHO) Risk Score for CVD Risk Assesment. In ASCVD Risk Score, we categorize population into low risk ( score <5), borderline(score between 5 and 7.4) ,intermediate( score between 7.5 an 19.9) and high risk (score>20), using all parameters for risk assesment. For WHO risk score calculation we are using WHO Risk score system for South Asia. https://cdn.who.int/media/docs/default-source/cardiovascular-diseases/south-asia.pdf?sfvrsn=c5b0d9a3_2

Secondary outcomes

  1. Cardiovascular risk reduction

    Time frame: Ten years

    CVD risk reduction in patients with or without established CVD but with CVD co morbids.

  2. Cardiovascular related deaths

    Time frame: Ten years.

    Estimation of patients who expired in their follow up despite CVD risk factors management.

Study contacts

Contact information is provided by the study sponsor or research team.

Dr Rubina Rauf

CONTACT

[email protected]

+923002947117

Musa Karim

CONTACT

[email protected]

+923323646169

Sponsors and collaborators

Lead sponsor

National Institute of Cardiovascular Diseases, Pakistan

Other

Registry information

Official study title

Assessment and Control of Modifiable Risk Factors for Primary and Secondary Prevention

Acronym: PREVENT-CARD

Important dates

Study start
2021
Primary completion
2031
Study completion
2041
First posted
Jul 16, 2024
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.